{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:16:11Z","timestamp":1790702171778,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["NRF-2019R1A2C1005523"],"award-info":[{"award-number":["NRF-2019R1A2C1005523"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.intimp.2023.110995","type":"journal-article","created":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T18:25:00Z","timestamp":1696443900000},"page":"110995","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"PB","title":["Therapeutic effects of candesartan in inflammatory skin disorders by suppressing Th17 differentiation"],"prefix":"10.1016","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1928-2288","authenticated-orcid":false,"given":"So-Eun","family":"Son","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8054-8946","authenticated-orcid":false,"given":"Dong-Soon","family":"Im","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.intimp.2023.110995_b0005","doi-asserted-by":"crossref","first-page":"4136","DOI":"10.4049\/jimmunol.169.8.4136","article-title":"Susceptibility to T cell-mediated injury in immune complex disease is linked to local activation of renin-angiotensin system: the role of NF-AT pathway","volume":"169","author":"Suzuki","year":"2002","journal-title":"Journal of Immunology"},{"issue":"1","key":"10.1016\/j.intimp.2023.110995_b0010","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijcard.2005.07.040","article-title":"Anti-inflammatory and metabolic effects of candesartan in hypertensive patients","volume":"108","author":"Koh","year":"2006","journal-title":"International Journal of Cardiology"},{"issue":"9","key":"10.1016\/j.intimp.2023.110995_b0015","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1291\/hypres.26.691","article-title":"Candesartan reduces oxidative stress and inflammation in patients with essential hypertension","volume":"26","author":"Dohi","year":"2003","journal-title":"Hypertension Research"},{"issue":"3","key":"10.1016\/j.intimp.2023.110995_b0020","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/hr.2009.212","article-title":"Candesartan effect on inflammation in hypertension","volume":"33","author":"Derosa","year":"2010","journal-title":"Hypertension Research"},{"issue":"3","key":"10.1016\/j.intimp.2023.110995_b0025","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1681\/ASN.2006070770","article-title":"Long-term, high-dosage candesartan suppresses inflammation and injury in chronic kidney disease: nonhemodynamic renal protection","volume":"18","author":"Yu","year":"2007","journal-title":"Journal of the American Society of Nephrology: JASN"},{"issue":"7","key":"10.1016\/j.intimp.2023.110995_b0030","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/sj.bjp.0707454","article-title":"Angiotensin AT1 receptor antagonists exert anti-inflammatory effects in spontaneously hypertensive rats","volume":"152","author":"Dai","year":"2007","journal-title":"British Journal of Pharmacology"},{"issue":"35","key":"10.1016\/j.intimp.2023.110995_b0035","doi-asserted-by":"crossref","first-page":"14948","DOI":"10.1073\/pnas.0903958106","article-title":"Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1-and TH17-mediated autoimmunity","volume":"106","author":"Platten","year":"2009","journal-title":"Proc Nat Acad Sci"},{"key":"10.1016\/j.intimp.2023.110995_b0040","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.peptides.2013.05.012","article-title":"Mechanisms of the anti-inflammatory actions of the angiotensin type 1 receptor antagonist losartan in experimental models of arthritis","volume":"46","author":"Silveira","year":"2013","journal-title":"Peptides"},{"issue":"1","key":"10.1016\/j.intimp.2023.110995_b0045","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000065177","article-title":"Effect of intranasal administration of CV-11974, a type 1 angiotensin II receptor antagonist, on airway hyperresponsiveness and airway inflammation induced by antigen inhalation in guinea pigs","volume":"129","author":"Myou","year":"2002","journal-title":"International Archives of Allergy and Immunology"},{"issue":"1","key":"10.1016\/j.intimp.2023.110995_b0050","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1164\/ajrccm.162.1.9907128","article-title":"Type 1 angiotensin II receptor antagonism reduces antigen-induced airway reactions","volume":"162","author":"Myou","year":"2000","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.intimp.2023.110995_b0055","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejphar.2019.02.035","article-title":"Suppressive effects of type I angiotensin receptor antagonists, candesartan and irbesartan on allergic asthma","volume":"852","author":"Kim","year":"2019","journal-title":"European Journal of Pharmacology"},{"issue":"5","key":"10.1016\/j.intimp.2023.110995_b0060","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1161\/01.HYP.0000123072.34629.57","article-title":"Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPAR\u03b3\u2013modulating activity","volume":"43","author":"Benson","year":"2004","journal-title":"Hypertension"},{"issue":"17","key":"10.1016\/j.intimp.2023.110995_b0065","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1161\/01.CIR.0000127955.36250.65","article-title":"Angiotensin type 1 receptor blockers induce peroxisome proliferator\u2013activated receptor-\u03b3 activity","volume":"109","author":"Schupp","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.intimp.2023.110995_b0070","doi-asserted-by":"crossref","first-page":"539","DOI":"10.4062\/biomolther.2018.006","article-title":"Suppressive Effect of 4-Hydroxy-2-(4-Hydroxyphenethyl) Isoindoline-1,3-Dione on Ovalbumin-Induced Allergic Asthma","volume":"26","author":"Huang","year":"2018","journal-title":"Biomolecules & Therapeutics"},{"issue":"6","key":"10.1016\/j.intimp.2023.110995_b0075","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1042\/CS20160645","article-title":"BAY 11\u20137082 inhibits the NF-\u03baB and NLRP3 inflammasome pathways and protects against IMQ-induced psoriasis","volume":"131","author":"Irrera","year":"2017","journal-title":"Clinical Science (London, England)"},{"issue":"6","key":"10.1016\/j.intimp.2023.110995_b0080","doi-asserted-by":"crossref","first-page":"594","DOI":"10.2340\/00015555-3160","article-title":"Inhibiting Sphingosine Kinase 2 Derived-sphingosine-1-phosphate Ameliorates Psoriasis-like Skin Disease via Blocking Th17 Differentiation of Naive CD4 T Lymphocytes in Mice","volume":"99","author":"Shin","year":"2019","journal-title":"Acta Dermato-Venereologica"},{"issue":"6","key":"10.1016\/j.intimp.2023.110995_b0085","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1042\/CS20160645","article-title":"BAY 11\u20137082 inhibits the NF-\u03baB and NLRP3 inflammasome pathways and protects against IMQ-induced psoriasis","volume":"131","author":"Irrera","year":"2017","journal-title":"Clinical Science"},{"issue":"3","key":"10.1016\/j.intimp.2023.110995_b0090","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4062\/biomolther.2018.131","article-title":"Deficiency of Sphingosine-1-Phosphate Receptor 2 (S1P2) Attenuates Bleomycin-Induced Pulmonary Fibrosis","volume":"27","author":"Park","year":"2019","journal-title":"Biomol Ther (seoul)"},{"issue":"2","key":"10.1016\/j.intimp.2023.110995_b0095","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.pharep.2018.12.009","article-title":"Fisetin and telmisartan each alone or in low-dose combination alleviate OVA-induced food allergy in mice","volume":"71","author":"Elkholy","year":"2019","journal-title":"Pharmacological Reports"},{"issue":"1","key":"10.1016\/j.intimp.2023.110995_b0100","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/imr.12622","article-title":"Mast cell-neural interactions contribute to pain and itch","volume":"282","author":"Gupta","year":"2018","journal-title":"Immunological Reviews"},{"issue":"1","key":"10.1016\/j.intimp.2023.110995_b0105","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/exd.12297","article-title":"Time-dependent progression from the acute to chronic phases in atopic dermatitis induced by epicutaneous allergen stimulation in NC\/Nga mice","volume":"23","author":"Kim","year":"2014","journal-title":"Experimental Dermatology"},{"issue":"11","key":"10.1016\/j.intimp.2023.110995_b0110","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1038\/jid.2008.111","article-title":"Possible pathogenic role of Th17 cells for atopic dermatitis","volume":"128","author":"Koga","year":"2008","journal-title":"Journal of Investigative Dermatology"},{"issue":"5","key":"10.1016\/j.intimp.2023.110995_b0115","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.jaci.2016.03.010","article-title":"Precision medicine in patients with allergic diseases: Airway diseases and atopic dermatitis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy","volume":"137","author":"Muraro","year":"2016","journal-title":"Asthma & Immunology, J Allergy Clin Immunol"},{"issue":"7503","key":"10.1016\/j.intimp.2023.110995_b0120","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nature13199","article-title":"Nociceptive sensory neurons drive interleukin-23-mediated psoriasiform skin inflammation","volume":"510","author":"Riol-Blanco","year":"2014","journal-title":"Nature"},{"issue":"7128","key":"10.1016\/j.intimp.2023.110995_b0125","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nature05505","article-title":"Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis","volume":"445","author":"Zheng","year":"2007","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.intimp.2023.110995_b0130","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.it.2012.11.005","article-title":"The IL-23\/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses","volume":"34","author":"Lowes","year":"2013","journal-title":"Trends in Immunology"},{"key":"10.1016\/j.intimp.2023.110995_b0135","doi-asserted-by":"crossref","DOI":"10.1590\/0001-3765201920180699","article-title":"Candesartan inhibits inflammation through an angiotensin II type 1 receptor independent way in human embryonic kidney epithelial cells","volume":"91","author":"Yu","year":"2019","journal-title":"An Acad Bras Ci\u00eanc"},{"key":"10.1016\/j.intimp.2023.110995_b0140","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.lfs.2015.03.005","article-title":"Telmisartan attenuated LPS-induced neuroinflammation in human IMR-32 neuronal cell line via SARM in AT1R independent mechanism","volume":"130","author":"Saravanan","year":"2015","journal-title":"Life Sciences"},{"issue":"4","key":"10.1016\/j.intimp.2023.110995_b0145","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/exd.12647","article-title":"The role of PPAR \u03b3-mediated signalling in skin biology and pathology: new targets and opportunities for clinical dermatology","volume":"24","author":"Ramot","year":"2015","journal-title":"Experimental Dermatology"},{"issue":"9","key":"10.1016\/j.intimp.2023.110995_b0150","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/j.1398-9995.2008.01677.x","article-title":"Activation of peroxisome proliferator-activated receptor gamma suppresses mast cell maturation involved in allergic diseases","volume":"63","author":"Tachibana","year":"2008","journal-title":"Allergy"},{"issue":"9","key":"10.1016\/j.intimp.2023.110995_b0155","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1038\/jid.2008.84","article-title":"Systemic PPAR\u03b3 ligation inhibits allergic immune response in the skin","volume":"128","author":"Dahten","year":"2008","journal-title":"Journal of Investigative Dermatology"},{"issue":"2","key":"10.1016\/j.intimp.2023.110995_b0160","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jaci.2010.10.043","article-title":"Peroxisome proliferator\u2013activated receptor \u03b3\u2013mediated suppression of dendritic cell function prevents the onset of atopic dermatitis in NC\/Tnd mice","volume":"127","author":"Jung","year":"2011","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"8","key":"10.1016\/j.intimp.2023.110995_b0165","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.bbalip.2007.02.013","article-title":"PPARs and molecular mechanisms of transrepression","volume":"1771","author":"Ricote","year":"2007","journal-title":"Biochim Biophys Acta - Mol Cell Biol Lipids"},{"issue":"6","key":"10.1016\/j.intimp.2023.110995_b0170","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1002\/art.21040","article-title":"Angiotensin receptor blockers suppress antigen-specific T cell responses and ameliorate collagen-induced arthritis in mice","volume":"52","author":"Sagawa","year":"2005","journal-title":"Arthritis Rheumatism"},{"issue":"5","key":"10.1016\/j.intimp.2023.110995_b0175","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1167\/iovs.08-2649","article-title":"Suppression of experimental autoimmune uveitis by angiotensin II type 1 receptor blocker telmisartan","volume":"50","author":"Okunuki","year":"2009","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"8","key":"10.1016\/j.intimp.2023.110995_b0180","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1172\/JCI41709","article-title":"Angiotensin II sustains brain inflammation in mice via TGF-\u03b2","volume":"120","author":"Lanz","year":"2010","journal-title":"The Journal of Clinical Investigation"},{"issue":"6","key":"10.1016\/j.intimp.2023.110995_b0185","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.cytogfr.2010.10.006","article-title":"Signal transduction pathways and transcriptional regulation in Th17 cell differentiation","volume":"21","author":"Hirahara","year":"2010","journal-title":"Cytokine & Growth Factor Reviews"},{"key":"10.1016\/j.intimp.2023.110995_b0190","article-title":"Repositioning of the Angiotensin II Receptor Antagonist Candesartan as an Anti-Inflammatory Agent With NLRP3 Inflammasome Inhibitory Activity","volume":"13","author":"Lin","year":"2022","journal-title":"Frontiers in Immunology"},{"issue":"2","key":"10.1016\/j.intimp.2023.110995_b0195","doi-asserted-by":"crossref","first-page":"e20180699","DOI":"10.1590\/0001-3765201920180699","article-title":"Candesartan inhibits inflammation through an angiotensin II type 1 receptor independent way in human embryonic kidney epithelial cells","volume":"91","author":"Yu","year":"2019","journal-title":"Anais da Academia Brasileira de Ci\u00eancias"},{"issue":"10","key":"10.1016\/j.intimp.2023.110995_b0200","doi-asserted-by":"crossref","DOI":"10.3390\/ph15101222","article-title":"Candesartan Attenuates Cisplatin-Induced Lung Injury by Modulating Oxidative Stress, Inflammation, and TLR-4\/NF-\u03baB, JAK1\/STAT3, and Nrf2\/HO-1 Signaling","volume":"15","author":"Atwa","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"issue":"10","key":"10.1016\/j.intimp.2023.110995_b0205","doi-asserted-by":"crossref","first-page":"6950","DOI":"10.1007\/s12035-015-9584-5","article-title":"Angiotensin Receptor Blockade Modulates NF\u03baB and STAT3 Signaling and Inhibits Glial Activation and Neuroinflammation Better than Angiotensin-Converting Enzyme Inhibition","volume":"53","author":"Bhat","year":"2016","journal-title":"Molecular Neurobiology"},{"key":"10.1016\/j.intimp.2023.110995_b0210","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13223-019-0340-7","article-title":"Variants in the IL17 pathway genes are associated with atopic asthma and atopy makers in a South American population","volume":"15","author":"Silva","year":"2019","journal-title":"Allergy, Asthma and Clinical Immunology"},{"issue":"6","key":"10.1016\/j.intimp.2023.110995_b0215","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.coi.2009.09.006","article-title":"Mast cells in atopic dermatitis","volume":"21","author":"Kawakami","year":"2009","journal-title":"Cur Opin Immunol"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923013206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923013206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:08:46Z","timestamp":1761588526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923013206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":43,"alternative-id":["S1567576923013206"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110995","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic effects of candesartan in inflammatory skin disorders by suppressing Th17 differentiation","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110995","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110995"}}